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 2 
Abstract 31 
Objectives: Indigenous Latin American populations have used extracts from Calophyllum 32 
brasiliense, a native hardwood, to treat gastrointestinal symptoms for generations. The hexane 33 
extract of Calophyllum brasiliense stem bark (HECb) protects against ethanol-mediated gastric 34 
ulceration in Swiss-Webster mice. We investigated whether HECb inhibits the development of 35 
gastric epithelial pathology following Helicobacter felis infection of INS-Gas mice. 36 
 37 
Methods: Groups of 5 male, 6-week-old INS-Gas mice were colonised with H. felis by gavage. 38 
From 2 weeks after colonisation their drinking water was supplemented with 2% Tween20 39 
(vehicle), low dose HECb (33 mg/L, lHECb) or high dose HECb (133 mg/L, hHECb). 40 
Equivalent uninfected groups were studied. Animals were culled 6 weeks after H. felis 41 
colonisation. Preneoplastic pathology was quantified using established histological criteria. 42 
Gastric epithelial cell turnover was quantified by immunohistochemistry for Ki67 and active-43 
caspase 3. Cytokines were quantified using an electrochemiluminescence assay. 44 
 45 
Results: Vehicle-treated H. felis infected mice exhibited higher gastric atrophy scores than 46 
similarly treated uninfected mice (mean atrophy score 5.6 ± 0.87 SEM vs 2.2 ± 0.58, p<.01). 47 
The same pattern was observed following lHECb. Following hHECb treatment, H. felis status 48 
did not significantly alter atrophy scores. Gastric epithelial apoptosis was not altered by H. felis 49 
or HECb administration. Amongst vehicle-treated mice, gastric epithelial cell proliferation was 50 
increased 2.8 fold in infected compared to uninfected animals (p<.01). Administration of either 51 
lHECb or hHECb reduced proliferation in infected mice to levels similar to uninfected mice. 52 
A Th17 polarised response to H. felis infection was observed in all infected groups. hHECb 53 
attenuated IFN-γ, IL-6 and TNF production following H.felis infection (70% (p<.01), 67% 54 
(p<.01) and 41 % (p<.05) reduction vs vehicle respectively). 55 
 56 
Conclusions: HECb modulates gastric epithelial pathology following H. felis infection of INS-57 
Gas mice. Further studies are indicated to confirm the mechanisms underlying these 58 
observations. 59 
 60 
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 3 
Introduction 64 
 65 
Gastric cancer is the third commonest cause of cancer death worldwide (Ferlay J, 2013). Over 66 
80% of patients with primary gastric adenocarcinoma have evidence of prior exposure to 67 
Helicobacter pylori. Curative treatment for gastric cancer relies on surgical or endoscopic 68 
resection of lesions, however many patients present late in the disease process and hence cannot 69 
be offered curative therapy. 70 
 71 
Established chemotherapeutic agents are available for patients with gastric cancer, but their 72 
efficacy is limited (Bauer et al., 2015). Another strategy that could be employed to reduce the 73 
burden of gastric cancer would be to develop chemopreventative strategies that retard the 74 
development of gastric cancer in at risk populations. Currently the only effective treatment 75 
strategy to achieve this is to eradicate H. pylori, but this strategy is becoming more challenging 76 
due to the emergence of antibiotic resistant organisms (Shiota et al., 2015), and is relatively 77 
ineffective in people who have established preneoplastic pathology (Ford et al., 2014), 78 
therefore novel therapeutic agents are needed. As 70% of novel chemotherapeutic agents are 79 
derived from plant materials (Newman and Cragg, 2012), the extraction and characterisation 80 
of novel, naturally occurring compounds is an important strategy for the identification of 81 
potentially important new drugs. 82 
 83 
Calophyllum brasiliense Cambessédes is a tropical hardwood tree of the Calophyllaceae family 84 
native to Latin America’s rainforests (Mesia-Vela et al., 2001; The Angiosperm Phylogeny, 85 
2016). Many parts of this tree, including the latex that exudes from its bark, have been used in 86 
folk medicine to treat a variety of symptoms, including those associated with the 87 
gastrointestinal tract (Corrêa, 1978; Reyes-Chilpa et al., 2006; Neto, 2012). The hexane extract 88 
of C. brasiliense stem bark (HECb) has been shown to protect against models of acute gastric 89 
ulceration in Swiss-Webster mice and Wistar rats. The majority of this extract is composed of 90 
two chromanones, Brasiliensic acid and Isobrasiliensic acid, these agents have been shown to 91 
contribute at least part of the gastroprotective activity of HECb (Lemos et al., 2012). 92 
 93 
As HECb and its chromanone fractions influence the development of gastric ulceration, we 94 
hypothesised that these agents may also influence the outcome of chronic Helicobacter 95 
infection, and may modulate the development of gastric cancer. To determine whether this is 96 
the case we adopted the established INS-Gas mouse / H. felis induced gastric pre-neoplasia 97 
 4 
model. In this model, constitutively hypergastrinaemic INS-Gas mice are colonised with H. 98 
felis for six weeks. Animals develop marked gastritis with atrophy and early pre-neoplastic 99 
lesions identifiable in the gastric corpus of infected mice (Wang et al., 2000; Thomson et al., 100 
2012; Burkitt et al., 2017). We have used this model to characterise how HECb administration 101 
influences gastric pre-malignancy and gastric cell turnover. 102 
 103 
Materials and Methods 104 
Botanical material 105 
The stem bark of C. brasiliense Cambess. was collected in June 2010 by LMSL (authorization 106 
number 22698-1 Ministério do Meio Ambiente, Brazil), at the source of the Coxipó River 107 
(S15◦38’40.8’’, W056◦03’05.6’’), Cuiabá, MT, Brazil. A voucher specimen (# 37993) was 108 
deposited at the Herbarium of Federal University of Mato Grosso (UFMT), Brazil, and was 109 
identified by Harri Lorenzi MSc, Instituto Plantarum de Estudos da Flora, Nova Odessa, SP, 110 
Brazil. The preparation of HECb, as well as brasiliensic (Bras. acid) and isobrasiliensic acid 111 
(Isobras. acid) isolation process, were as previous described (Lemos et al., 2016). 112 
 113 
Animals 114 
All animal procedures were performed at the University of Liverpool with UK Home Office 115 
approval. In-vivo experiments were performed in male INS-Gas mice on the FVB/N (Wang et 116 
al., 1993) background bred and maintained at the University of Liverpool Biomedical Services 117 
Unit. Primary gastric gland cultures were generated from male C57BL/6 mice acquired from 118 
Charles River, Margate, UK. 119 
 120 
Helicobacter felis colonisation experiments 121 
H. felis (ATCC 49179) was cultured for 72-96 h at 37C on Columbia chocolate agar plates in 122 
a microaerophilic environment generated by Campygen atmosphere generating packs in an 123 
anaerobic jar (all Oxoid, Basingstoke, UK). For colonization of mice, the organism was 124 
harvested into tryptone soy broth and bacterial density was estimated by optical density at 125 
600nm. An estimated bacterial density in excess of >108 CFU/mL was required to progress to 126 
gavage. 127 
 128 
Groups of at least 5 male INS-Gas aged six weeks were administered 0.5ml H. felis suspension 129 
by oro-gastric gavage on three occasions over one week. Successful H. felis colonisation was 130 
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confirmed 2 weeks after the final gavage procedure by quantitative PCR for FlaA in fecal DNA 131 
(Duckworth et al., 2015b). At this time drinking water was supplemented with 2% Tween 20, 132 
HECb 33 mg/L (lHECb, approximately 10 mg/kg/day) or HECb 133 mg/L (hHECb, 133 
approximately 40 mg/kg/day) and made available ad-libitum. Equivalent uninfected control 134 
groups were also studied. Animals were culled by cervical dislocation 6 weeks after H. felis 135 
colonisation. Corpus and antrum mucosal samples were taken for histopathology and 136 
immunohistochemistry studies. The remainder of gastric tissue was homogenised in PBS with 137 
protease inhibitor for quantification of cytokines by electrochemiluminescent assay. 138 
 139 
Histological procedures 140 
Gastric tissues were fixed in 4% formalin in PBS for a minimum of 12h, processed into paraffin 141 
wax embedded blocks by standard methods and sectioned at 4μm thickness for all staining 142 
techniques. Corpus and antrum were stained with hematoxylin and eosin (HE) for 143 
histopathological evaluations. Immunohistochemical analysis of corpus was also performed. 144 
 145 
Immunohistochemistry 146 
Gastric corpus mucosa was labeled by immunohistochemistry for proliferation (Ki67 primary 147 
antibody, AbCam, Cambridge, UK), apoptosis (cleaved caspase 3, AF835, R and D Systems, 148 
Minneapolis, MN), and tyrosine 204 phosphorylation state specific ERK (sc-7383, SantaCruz 149 
Biotechnology, Dallas, TX) by immunohistochemistry. All primary antibodies were raised in 150 
rabbit and were visualised using the Impress HRP system (Vector laboratories, Peterborough, 151 
UK). 152 
 153 
Quantitative histological methods 154 
Histological tissue sections were scored by an investigator blinded to sample identity, using a 155 
modified visual analogue scale(Rogers, 2012). To quantify cell numbers in the gastric corpus 156 
mucosa, 10 areas per mouse, with well oriented gastric glands, forming a well visualized 157 
epithelial monolayer were chosen. Ki67 scoring was performed using a 10x10 mm eyepiece 158 
graticule divided into 1 mm squares which was overlapped along the chosen area using a x40 159 
objective. Number of positive cells per square were recorded as previously described (Burkitt 160 
et al., 2013). Apoptotic and ERK phosphorylation events were scored by examining the number 161 
of positively stained cells in 10 high powered fields per section, using a x63 objective. All 162 
results were expressed as mean ± SEM.  163 
 164 
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Electrochemiluminescence immunoassay analysis 165 
Twelve cytokines were measured in the same samples of gastric homogenate of mice infected 166 
or not with H. felis by multiplexed electrochemiluminescence cytokine immunoassays (Meso 167 
Scale Discovery, Gaithersburg, USA). Specifically these were a Th1/Th2 standard 10-plex 168 
panel consisting of IFN-ϒ, IL-1β, IL-2, IL-4, IL-5, KC-GRO, IL-10, IL-12 p70, IL-13, and 169 
TNF. In addition, simplex IL-17 and IL-23 assays were performed in parallel, as Th17 170 
responses are strongly associated with Helicobacter infections. The part of the stomach 171 
between corpus and antrum of H felis infected and uninfected INS-Gas mice was homogenized 172 
twice in PBS with protease inhibitors (SigmaFast, Sigma Aldrich, UK), using the TissueLyserII 173 
(QIAGEN, Tokyo, Japan) at 25Hz for 3 min. After centrifugation (4°C, 12,000 rpm, 10 min), 174 
supernatants were transferred to a clean tube, and stored at −80°C until use. Immediately before 175 
analysis, samples were clarified by further centrifugation (4 °C, 12,000 rpm, 10 min). 176 
Electrochemiluminescence analysis was performed according to the manufacturer’s 177 
instructions. A standard curve for each analyte was curve-fitted and allowed determination of 178 
the concentration in pg cytokine/mL. 179 
 180 
Murine primary gastric gland cultures 181 
Gastric epithelial cultures were generated as previously described (Duckworth et al., 2015a) 182 
and were maintained in 12-well tissue culture plates on glass cover slips (Appleton Woods, 183 
Selly Oak, UK) that contained 1.0mL/well DMEM-Ham’s F-12 mix (Sigma Aldrich), 10% 184 
fetal calf serum (Invitrogen, Paisley, UK), 1.25% L-glutamine (Sigma Aldrich), and 1% 185 
antibiotic/antimycotic mixture (Sigma Aldrich). Following digestion and plating, glands were 186 
maintained at 37°C in a humidified environment containing 5% CO2 for 24h. Media was 187 
changed to fresh complete media after a further 24h. 48h after initial plating, cells were treated 188 
with HECb, brasiliensic and isobrasiliensic acids (12.5 to 100 µg/mL) for 24h, 2 hours before 189 
fixation EdU was added to the culture media. Cells were fixed in 2% formaldehyde for 30 min 190 
followed by three washes in PBS. Treatments were repeated a minimum of 4 times using glands 191 
extracted from a different mouse on each occasion.  192 
 193 
Immunofluorescence 194 
Primary glands were immunolabeled for cleaved caspase 3 and EdU. Two hours before the end 195 
of treatment, 200µL of treatment media was replaced by 200µL of 10µM EdU and incubated 196 
to complete the treatment. Cultures were washed and fixed with 2% paraformadehyde in PBS 197 
for 30 min. Following fixation, EdU intercalation was labelled using the Click-iT EdU Alexa 198 
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Fluor 594 Imaging Kit (Invitrogen, Paisley, UK) as per protocol. Subsequently non-specific 199 
protein binding was blocked with 10% goat serum and apoptotic cells were labelled with a 200 
rabbit anti-cleaved caspase 3 antibody (AF835, Cell Signalling, Beverly, MA, USA) and 201 
visualised with Alexa fluor 488 conjugated donkey anti-rabbit immunoglobulins (Invitrogen). 202 
Coverslips were mounted with Vectashield with DAPI (Vector Labs). Slides were observed 203 
using a standard Nikon fluorescent microscope, and proliferative and apoptotic events were 204 
quantified as previously described (Duckworth et al., 2015a). 205 
 206 
Human gastric cancer cell culture 207 
The human gastric adenocarcinoma cell line AGS (ATCC CRL 1739) were grown in complete 208 
medium, consisting of Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% 209 
fetal calf serum, 1% L-glutamine and 1% penicillin/streptomycin at 37◦C in 5% CO2 210 
atmosphere with humidity. 211 
 212 
Flow cytometry 213 
AGS cells (106 cells/well) were seeded in 12-well plates, then treated or not with HECb, 214 
brasiliensic and isobrasiliensic acids (12.5, 25 and 50 µg/mL) for 24h. Cells were harvested, 215 
washed with phosphate-buffered saline (PBS), fixed with cold 70% ethanol and kept at -20°C 216 
until use. Cells were washed three times with PBS and stained with a solution of ribonuclease 217 
A (R4875, Sigma-Aldrich, Sao Paulo, BR) at 50 ug/mL and propidium iodide (P4170, Sigma-218 
Aldrich, Sao Paulo, BR) at 20 ug/mL in PBS for 90 min, cell cycle distribution was determined 219 
by flow cytometric analysis using a BD AccuriTM C6 (BD, New Jersey, USA).  220 
 221 
Western blotting and blot densitometry 222 
AGS cells (2×106 cells/well) were seeded in 6-well plates, pretreated with HECb (12.5, 25 and 223 
50 µg/mL) and a highly selective MEK1 inhibitor (PD98059) at 10mM for 24h. Cultures were 224 
subsequently infected with H. pylori at a MOI of 300:1 for 1h. After incubation, cells were 225 
lyzed in ice-cold RIPA buffer supplemented with protease cocktail and phosphatase inhibitors 226 
(Sigma Fast, 10mM sodium orthovanadate, 10mM sodium pyrophosphate and sodium fluoride 227 
100mM).  228 
 229 
Protein lysates were subjected to SDS-PAGE before being immobilized onto nitrocellulose 230 
membranes (Biorad, USA). After transfer, membranes were blocked (20mM Tris-HCl, pH 7.4, 231 
125mM NaCl, 0.2% Tween 20, 1% bovine serum albumin, 3% non-fat milk) for 1h at room 232 
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temperature and incubated for 4h at 4°C with specific primary antibodies: p-ERK1/2 and β-233 
actin (as above, Santa Cruz Biotechnology, TX, USA). Blots were incubated with secondary 234 
antibody rabbit anti-mouse IGG-HRP (sc-358914, Santa Cruz Biotechnology, TX, USA) and 235 
immunoreactive bands were visualized by chemiluminescence (ECL Amersham, USA) and 236 
detected with ChemiDoc XRS system™ software and subsequently analyzed with Image 237 
Lab™ (Biorad, CA, USA).  238 
 239 
Statistical analysis 240 
Statistical analysis was performed using GraphPad Prism 6 software. Data represent mean ± 241 
SEM. Comparisons were made using 1-way or 2-way ANOVAs and Tukey’s or Sidak’s post-242 
hoc analysis as appropriate. p<.05 was considered significant.  243 
 244 
Results 245 
HECb protects against H. felis induced pre-neoplasia in INS-Gas mice 246 
To determine whether the administration of HECb affected the outcome of H. felis induced 247 
gastric pre-neoplasia, groups of 5 six-week old male INS-Gas mice were infected with H. felis 248 
by oro-gastric gavage, two weeks later drinking water was supplemented with hHECb, lHECb 249 
or vehicle (2% Tween 20). This treatment was maintained until the end of the procedure 6 250 
weeks after the final dose of H. felis. At the end of the procedure, animals were culled and 251 
gastric epithelial tissues prepared for quantitative histopathology and electrochemiluminescent 252 
cytokine analysis. Control groups that underwent changes to their water supply, but did not 253 
receive H. felis were also maintained. 254 
 255 
Pathological gastric lesions were quantified using an established visual analogue scoring tool. 256 
Uninfected animals had low combined pathology scores (mean score 2.2 +/- 0.58), with no 257 
significant differences observed in mice exposed to HECb compared to those receiving vehicle. 258 
The administration of H. felis led to the development of marked gastric corpus pathology in 259 
the vehicle group (5.6 +/- 0.87). lHECb appeared to have no impact on development of gastric 260 
corpus neoplasia at this timepoint, with similar composite pathology scores (7.2 +/- 0.37) 261 
compared to vehicle treated, H. felis infected mice. In contrast, composite pathology scores 262 
were partially attenuated in animals co-administered hHECb (4.0 +/- 0.45) (Figure 1A and B). 263 
At this time-point, treatment with HECb had no discernable effect on inflammatory cell 264 
infiltration or parietal cell loss (Figure 1 C and D), however the gastric mucosa was 1.9 times 265 
thicker in vehicle treated H. felis infected mice compared to vehicle treated uninfected mice 266 
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(p<.05). In HECb treated mice H. felis infection did not significantly alter mucosal thickness 267 
(Figure 1 E), and mucous metaplasia was decreased on morphological scoring criteria in H. 268 
felis infected mice receiving hHECB (Figure 1F). 269 
  270 
To further characterize the gastric epithelial immune response to H. felis infection in this model 271 
mucosal cytokine abundance was determined by electrochemiluminescent assay. Colonisation 272 
with H. felis induced a Th17 polarised immune response, as previously demonstrated in this 273 
and other mouse models of Helicobacter induced gastric pre-neoplasia (Figure 2A). 274 
 275 
Administration of either vehicle or HECb did not alter this overall response, however, there 276 
were subtle changes in the abundance of individual cytokines. Amongst H. felis infected mice 277 
IFN-, TNF and IL-6 were all less abundant (3.3 fold, 3.1 fold and 1.7 fold respectively) in 278 
animals administered hHECb compared to those treated with vehicle. Treatment with lHECb 279 
also induced an apparent, though statistically not-significant, reduction in IFN- and IL-6 280 
abundance, supportive of a dose response effect for HECb on production of these cytokines. 281 
lHECb had minimal impact on TNF abundance compared to vehicle (Figure 2C-E). The 282 
abundance of KC-GRO, a mouse homolog for IL-8, in vehicle treated mice was 10.9 fold more 283 
abundant in mice colonized with H. felis, compared to the uninfected group, this cytokine was 284 
unaffected by the administration of HECb (Figure 2F). These observations suggest that 285 
treatment with HECb minimally attenuates the inflammatory response induced by H. felis.  286 
  287 
HECb influences gastric epithelial remodeling by altering epithelial cell turnover in 288 
response to Helicobacter felis in-vivo 289 
The observation that H. felis induced metaplasia was less abundant in mice treated with hHECb 290 
led us to hypothesize that HECb treatment might influence epithelial remodeling, either 291 
impacting de-differentiation of mature cell lineages, or influencing epithelial cell turnover. To 292 
characterize this, quantitative histology was used to determine the number of Ki67 positive 293 
proliferating cells (Figure 3A), and cleaved caspase 3 positive (Figure 3C) apoptotic cells in 294 
the gastric corpus mucosa of mice.  295 
 296 
A mean apoptotic index of 3.8 (± 0.53) cells per high powered field (hpf) was demonstrated in 297 
vehicle treated, uninfected mice. This did not change significantly following H. felis infection, 298 
or administration of HECb (Figure 3D). In contrast H. felis infection had a profound impact on 299 
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abundance of Ki67 immunopositive cells. Uninfected mice treated with Tween20 had a 300 
proliferation index of 20.5 (± 3.2), which was similar to the proliferation index of uninfected 301 
mice treated with HECb. Following H. felis infection vehicle treated mice exhibited a 2.8 fold 302 
increase in proliferative index (p<0.01, Figure 3B). When HECb was administered at either 303 
dose Ki67 abundance was significantly lower in infected mice compared to vehicle treated 304 
controls (2.3 fold and 2.2 fold reductions for hHECb and lHECb respectively, p<.01), leading 305 
to proliferation indices similar to those seen in uninfected mice. 306 
 307 
HECb induced suppression of proliferation is an epithelial cell event 308 
To determine whether the anti-proliferative effect of HECb observed in H. felis infected INS-309 
Gas mice was driven purely by its apparently modest influence on inflammation, or through an 310 
immune cell independent mechanism, primary cultures of murine gastric glands were 311 
generated. In our hands these cultures can be maintained for in excess of 5 days, and have 312 
previously been shown to contain cells of each of the major gastric epithelial lineages 313 
(Duckworth et al., 2015a).  314 
 315 
Cultures were generated from male C57BL/6 mice. On the third day of culture, gastric glands 316 
were treated with rising concentrations of HECb or its constituents, brasiliensic acid and 317 
isobrasiliensic acid. Cells were fixed at 24h. Epithelial cell proliferation was assayed by 318 
quantifying the percentage of cells that had intercalated EdU, apoptosis was quantified by 319 
immunofluorescence for cleaved caspase-3. Each treatment was performed on cultures derived 320 
from 4 individual mice. 321 
 322 
In untreated cultures, 8.2 % (± 0.58) of cells intercalated EdU into their DNA. At different 323 
doses of treatment with HECb, brasiliensic acid and isobrasiliensic acid all suppressed 324 
proliferation (Figure 4A-C). Significant suppression of proliferation was observed following 325 
treatment with HECb at doses in excess of 25g/mL. Brasiliensic acid partially suppressed 326 
proliferation at 12.5g/mL and had more pronounced effects at doses in excess of 25g/mL. 327 
Isobrasiliensic acid suppressed proliferation at doses of 50g/mL and 100g/mL. 328 
 329 
All three compounds also induced apoptotic responses. Cytotoxicity in this model occured 330 
following treatment with 100g/mL of HECb or Brasiliensic acid. 100g/mL HECb induced 331 
a 13.3 fold increase in apoptosis compared to untreated glands (42% apoptotic cells, p<0.001), 332 
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whilst 100g/mL Brasiliensic acid triggered 55% (p<0.0001) of cells to become apoptotic. 333 
Isobarasiliensic acid treatment induced apoptosis at both 50g/mL and 100g/mL with 334 
respectively 31% and 52% of cells shown to be apoptotic (Figure 4 D-F). These observations 335 
demonstrate that HECb and its constituents induce cell cycle arrest and apoptosis in 336 
untransformed epithelial cell culture, suggesting that there is a direct epithelial effect of these 337 
compounds.  338 
 339 
To characterize whether the impact of HECb and its constituents on gastric epithelial cell 340 
proliferation was an isolated phenomenon in the ex-vivo culture setting, or whether the same 341 
effects are identifiable in transformed cell lines, the cell cycle dynamics of AGS cells treated 342 
with HECb and its constituent chromanones was characterized by propidium iodide FACS 343 
analysis. Experiments were repeated a total of 4 times for each treatment. 344 
 345 
In untreated AGS cultures, 0.11 % (± 0.02 %) of cells were identified in the pre-G1 apoptotic 346 
phase, 37.7 % (± 1.14 %) were in the G1 phase, 21.8 % (± 2.52 %) of cells were in S phase and 347 
35.7 % (± 1.7 %) were in G2M phase (Figure 5). No increase in the proportion of cells in pre-348 
G1 was observed when AGS cells were treated with HECb or its constituents at 25g/mL or 349 
50g/mL. This is in keeping with our findings in primary cell culture where apoptosis was not 350 
induced when these concentrations were tested.  351 
 352 
HECb significantly decreased the proportion of cells in S-phase at both 25g/mL and 50g/mL 353 
(9.9% and 8.3% of cells in S-phase respectively, Figure 5A), with a reciprocal increase in 354 
proportion of cells in G1 (45.5% and 54.9%, p<.05 and p<.0001 respectively for 25g/mL and 355 
50g/mL HECb). Brasiliensic acid induced a similar reduction in percentage of cells in S-356 
phase at a dose of 50g/mL (13.0% of cells in S-phase, p<.01 Figure 5B), with an increase in 357 
proportion of cells in G1 observed (52.3%, p<.01). Both 25g/mL and 50g/mL isobrasiliensic 358 
acid also reduced the proportion of cells in S-phase compared to control (11.5% and 9.4% of 359 
cells in S-phase respectively, both p<.01 Figure 5C). Intriguingly however lower dose 360 
isobrasiliensic acid induced an increase in proportion of cells in G1 (52.9 %, p<.001), similar 361 
to that observed in cells treated with either HECb or brasiliensic acid, whilst higher dose 362 
isobrasiliensic acid appeared to induce G2M arrest with an increase in the number of cells in 363 
this phase (45.4 %, p<.05). 364 
 365 
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These data demonstrate that HECb and its constituents are capable of inducing cell cycle arrest 366 
in transformed cell lines. The evidence that isobrasiliensic acid induced G1 arrest at low dose 367 
and G2M arrest at higher doses attests to these compounds potentially acting through more 368 
than one mechanism, dependent upon the drug dosing regime. 369 
 370 
HECb suppresses Helicobacter induced phosphorylation of ERK in-vitro and in-vivo 371 
To further characterize how HECb affects Helicobacter induced proliferation, we pre-treated 372 
AGS cells with either HECb or the MEK 1 inhibitor PD98025 for 24 hours. Subsequently cells 373 
were co-cultured with H. pylori at a multiplicity of infection of 300:1 for 1h. A well 374 
characterized strain of H. pylori was used for these asssays, rather than H. felis as the effects 375 
of this organism on human cell culture are better characterized than those of H. felis, and H. 376 
pylori infection is more relevant to human disease.  377 
 378 
The abundance of p-ERK in whole cell lysates was quantified by Western blotting. All 379 
experiments were repeated 3 times. Blot densitometry was performed to quantify relative 380 
expression of p-ERK compared to pan-actin abundance.  381 
 382 
Exposure of AGS cells to Helicobacter pylori for 1h induced phosphorylation of ERK 1 and 383 
2. When cells were pre-treated with HECb we observed significantly less phosphorylation of 384 
ERK at all doses that were administered (Figure 6A and B). 385 
 386 
To determine whether ERK phosphorylation was also involved in the reduction of gastric 387 
epithelial cell proliferation in response to H. felis infection, in-vivo gastric corpus tissue 388 
samples from mice infected with H.felis or not, and treated with hHECb, lHECb or vehicle 389 
were immunostained for p-ERK. The number of cells expressing p-ERK was determined by 390 
quantitative immunohistochemistry. 391 
 392 
The gastric corpus of vehicle treated, uninfected mice exhibited 1.3 (± 0.2) p-ERK positive 393 
cells per high power field. Administration of HECb did not significantly influence this in 394 
uninfected mice, however administration of H. felis induced a 6.4 fold (p<.001) increase in p-395 
ERK positive cells in mice treated with vehicle. H. felis induced phosphorylation of ERK was 396 
almost entirely suppressed by treatment with either of the tested doses of HECb (Figure 6C 397 
and D).  398 
 399 
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This suggests that regulation of a classical MAPK pathway may be targeted directly or 400 
indirectly by HECb administration both in-vitro and in-vivo. 401 
 402 
Discussion: 403 
 404 
The data presented here provide further evidence that the oral administration of HECb 405 
influences the outcome of gastric epithelial injury. These effects were observed in the context 406 
of minimal changes in inflammatory phenotype with only a modest reduction in cytokine 407 
production in hHECb treated mice and no difference in morphological inflammation. It 408 
therefore appears likely that HECb acts predominantly through a protective effect on the gastric 409 
epithelium. This is in keeping with previous studies which demonstrated mucosal protection 410 
by HECb and some of its fractions during stress or chemically induced gastric ulceration 411 
(Sartori et al., 1999). In rats with ethanol induced gastric lesions HECb administration led to 412 
the inhibition of malondialdehyde and catalase activity suggesting that this gastroprotective 413 
role is, in part, due to an antioxidant effect (Lemos et al., 2012). 414 
 415 
The mechanism by which HECb influences gastric epithelial homeostasis remains 416 
incompletely understood, however we have now shown that it suppresses proliferation in 417 
gastric epithelial cells both in untreated primary cell culture and in transformed cell lines. In 418 
addition we have shown that Helicobacter felis induced proliferation is suppressed in-vivo by 419 
this compound. In-vitro we also demonstrated marked gastric epithelial cell cytotoxicity at 420 
higher doses of HECb (100μg/mL). However at doses used in-vivo this was not observed, 421 
suggesting that effective pharmacological doses probably did not reach this toxic 422 
concentration.  423 
 424 
To understand how HECb influences proliferation at a molecular level we have characterized 425 
the phosphorylation of ERK. ERK is phosphorylated in response to Helicobacter co-culture 426 
in-vitro, whilst administration of HECb suppresses Helicobacter associated phosphorylation 427 
of ERK. In-vivo we also observed marked suppression of Helicobacter induced 428 
phosphorylation of ERK when mice were treated with HECb. This suggests that HECb 429 
interacts with the Ras-Raf-MEK-ERK pathway, though it remains unclear whether this is 430 
through direct interaction with a pathway member, or whether this effect is secondary to 431 
interaction with upstream regulators of the pathway. Further mechanistic studies aiming to 432 
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characterize the precise interaction of HECb and its constituents with mammalian proteins are 433 
indicated to enable us to understand the mechanism of action of this extract.  434 
 435 
Due to the complexity of extracting the constituent chromanones from HECb it has not been 436 
possible to characterize the effects of either brasiliensic or isobrasiliensic acids on murine pre-437 
neoplastic pathology. However observations from ex-vivo and in-vitro cell culture models 438 
suggest that both of these agents are able to influence gastric epithelial cell turnover. In 439 
untransformed cells, brasiliensic acid appeared to have the widest potential therapeutic window 440 
where epithelial cell proliferation was suppressed, but apoptosis had not been induced (between 441 
12.5g/mL and 100g/mL), however the effect of these doses of brasiliensic acid on the 442 
proliferation of transformed cell lines was more modest, and isobrasiliensic acid at doses of 443 
25g/mL and 50g/mL were required to induce cell cycle arrest. In ths model an increase in 444 
apoptosis was not observed at the tested doses. Intriguingly we also demonstrated that high 445 
doses of isobrasiliensic acid induced a G2M cell cycle arrest as opposed to the G1 arrest 446 
observed following administration of either low dose isobrasiliensic acid, or HECb or 447 
brasiliensic acid at any dose tested.  448 
 449 
Chromanones synthesized or extracted from diverse sources have previously been assessed and 450 
shown to exhibit diverse pharmacological functions (including antimicrobial (Xu et al., 1998; 451 
Kanokmedhakul et al., 2002; Cottiglia et al., 2004; do Nascimento et al., 2007; Tanaka et al., 452 
2009), anti-oxidant (Lee et al., 2005) and anti-inflammatory effects (Konieczny et al., 1976), 453 
as well as effects on cardiac muscle repolarization (Wang et al., 2014) and coronary artery 454 
vasodilation (Nagao et al., 1972)). This diversity of pharmacological activity supports our cell-455 
cycle data which may suggest divergent mechanisms of action for brasiliensic and 456 
isobrasiliensic acids at higher doses. 457 
 458 
The differences in drug doses that induce apoptosis and cell cycle arrest suggest that there may 459 
be therapeutic windows in which these compounds could be used to induce gastric cell cycle 460 
arrest without inducing cytotoxicity. These findings support the need for further studies to 461 
investigate whether HECb and its constituents may influence the process of human gastric 462 
carcinogenesis. 463 
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Figure Legends: 587 
 588 
Figure 1: Evaluation of gastric corpus pathology of INS-Gas mice infected or not with 589 
Helicobacter felis for 6 weeks and treated with 33 mg/L (lHECb) or 133 mg/L (hHECb) ad 590 
libitum for the final 4 weeks. (A) Representative photomicrographs of HE-stained sections of 591 
gastric corpus, scale bar = 50μm. Histopathologic scoring results of (B) composite atrophy 592 
pathology (C) inflammation (D) oxyntic gland atrophy (E) mucosal thickness and (F) 593 
metaplasia. Two-way ANOVA followed by Sidak´s multiple comparison post-hoc test. All 594 
data are mean ± SEM of 5 mice. *p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 vs. 595 
uninfected mice with the same treatment. 596 
 597 
Figure 2: Effect of HECb on cytokine abundance in homogenate from the stomachs of INS-598 
Gas mice infected or not with Helicobacter felis for 6 weeks and treated with 33 mg/L (lHECb) 599 
or 133 mg/L (hHECb) ad libitum for the final 4 weeks, by electrochemoluminescence assay. 600 
(A) Th1 and Th17 ratio response, abundance of (B) IL-17, (C) IFN-γ, (D) TNF, (E) IL-6 and 601 
(F) KC-GRO in gastric tissue. Two-way ANOVA followed by Tukey’s multiple comparison 602 
post-hoc test. All data are means ± SD of 5 mice. *p<0.05, ***p<0.001, ****p<0.0001 vs. 603 
uninfected mice with the same treatment, θθ p<0.01 vs. Tween 20 control group with the same 604 
infection status.  605 
 606 
Figure 3: Effect of HECb on cell turnover in gastric corpus of INS-Gas mice infected or not 607 
with Helicobacter felis for 6 weeks and treated with 33 mg/L (lHECb) or 133 mg/L (hHECb) 608 
ad libitum for the final 4 weeks. (A) Representative photomicrographs of proliferating cells 609 
immunostained with Ki67 and (B) graph showing Ki67 positive cells scored, scale bars 50μm 610 
(C) representative photomicrographs of apoptotic cells immunostained for cleaved caspase-3 611 
and (D) graph showing the number of cleaved caspase 3 positive cells per high powered fields. 612 
Two-way ANOVA followed by Tukey’s multiple comparison post-hoc test. All data are mean 613 
± SEM of 5 mice. ** p<0.01 vs. uninfected mice with the same treatment, θ p<0.05 vs. Tween20 614 
control group with the same infection status. 615 
 616 
Figure 4: Effects of HECb on cell turnover of murine primary gastric epithelial cell cultures 617 
treated with HECb, brasiliensic acid or isobrasiliensic acid (12.5-100 µg/mL) for 24h, 618 
evaluated by immunofluorescence. Data expressed as percentage of proliferating cells 619 
following (A) HECb, (B) brasiliensic acid and (C) isobrasiliensic acid and percentage of 620 
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apoptotic cells following (D) HECb, (E) brasiliensic acid and (F) isobrasiliensic acid. Two-621 
way ANOVA followed by Tukey’smultiple comparison post-hoc test. All data are mean ± SD 622 
n=4. ** p<0.01 *** p<0.001, **** p<0.0001 vs. untreated cells. 623 
 624 
Figure 5: Effect of HECb and its constituents on cell cycle of transformed gastric epithelial 625 
cells. AGS cells were treated with HECb, brasiliensic acid or isobrasiliensic acid (25 or 626 
50µg/mL) or untreated for 24h and stained with propidium iodide. Figure A shows 627 
representative plots from untreated and HECb treated cells demonstrating the shift in 628 
distribution of cels byl cell cycle phase folowing HECb administration. Figures B-D show the 629 
mean percentage of cells (+/- SEM) in PreG1, G1, S and G2M phases of cell cycle, HECb (B), 630 
brasiliensic acid (C) and isobrasiliensic acid (A). Two-way ANOVA followed by Tukey’s post 631 
hoc analysis. * p<0.05 ** p<0.01 *** p<0.001, **** p<0.0001 vs. untreated cells in the same 632 
phase of cell cycle. 633 
 634 
Figure 6: Effect of HECb on Helicobacter induced phosphorylation of ERK in-vitro and in-635 
vivo. AGS cells were pretreated with HECb (12.5-50µg/mL) for 24h, and infected with 636 
Helicobacter pylori (MOI 1:300) for 1h . A. p-ERK1/2 abundance relative to β actin. One-way 637 
ANOVA, followed by Sidak´s post-hoc test. Data are mean ± SD n=3. **** p<0.0001 vs. 638 
untreated, uninfected cells. B. representative western blotting. Phosphorylation was estimated 639 
in relation to the relative amount of the endogenous β-actin control. Each line represents the 640 
mean of 3 independent experiments. C. Effect of HECb on ERK1/2 phosphorylation in gastric 641 
corpus of INS-Gas mice infected or not with Helicobacter felis for 6 weeks and treated with 642 
33 mg/L (lHECb) or 133 mg/L (hHECb) ad libitum for the final 4 weeks. Means ± SEM. N=5. 643 
***p<0.001 vs. uninfected mice with the same treatment, ## p<0.01, ###p<0.001 vs. Tween 20 644 
control group with the same infection status. D. Representative photomicrographies of ERK1/2 645 
immunostaining, scale bar = 25μm. 646 
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